WO2005076005A3 - A method for classifying a tumor cell sample based upon differential expression of at least two genes - Google Patents

A method for classifying a tumor cell sample based upon differential expression of at least two genes Download PDF

Info

Publication number
WO2005076005A3
WO2005076005A3 PCT/EP2005/000858 EP2005000858W WO2005076005A3 WO 2005076005 A3 WO2005076005 A3 WO 2005076005A3 EP 2005000858 W EP2005000858 W EP 2005000858W WO 2005076005 A3 WO2005076005 A3 WO 2005076005A3
Authority
WO
WIPO (PCT)
Prior art keywords
classifying
cell sample
tumor cell
genes
differential expression
Prior art date
Application number
PCT/EP2005/000858
Other languages
French (fr)
Other versions
WO2005076005A2 (en
Inventor
Christian Stratowa
Ulrich Koenig
Peter Steinlein
Stefan Amatschek
Herbert Auer
Wolfgang Sommergruber
Martin Schreiber
Agnes Gruenfelder
Margit Pacher-Zavisin
Original Assignee
Univ Wien Med
Christian Stratowa
Ulrich Koenig
Peter Steinlein
Stefan Amatschek
Herbert Auer
Wolfgang Sommergruber
Martin Schreiber
Agnes Gruenfelder
Margit Pacher-Zavisin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wien Med, Christian Stratowa, Ulrich Koenig, Peter Steinlein, Stefan Amatschek, Herbert Auer, Wolfgang Sommergruber, Martin Schreiber, Agnes Gruenfelder, Margit Pacher-Zavisin filed Critical Univ Wien Med
Publication of WO2005076005A2 publication Critical patent/WO2005076005A2/en
Publication of WO2005076005A3 publication Critical patent/WO2005076005A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Abstract

Described is a method for classifying a cell sample as being a tumor cell comprising detecting a difference in the expression by said cell sample of at least one gene of Table 4 relative to at least one control cell and classifying the cell sample as a tumor cell, if the at least one gene of Table 4 shows at least 1,5-fold higher expression than the control cell.
PCT/EP2005/000858 2004-01-30 2005-01-28 A method for classifying a tumor cell sample based upon differential expression of at least two genes WO2005076005A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04450020.5 2004-01-30
EP04450020 2004-01-30

Publications (2)

Publication Number Publication Date
WO2005076005A2 WO2005076005A2 (en) 2005-08-18
WO2005076005A3 true WO2005076005A3 (en) 2009-02-05

Family

ID=34833853

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2005/000858 WO2005076005A2 (en) 2004-01-30 2005-01-28 A method for classifying a tumor cell sample based upon differential expression of at least two genes

Country Status (1)

Country Link
WO (1) WO2005076005A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107312854A (en) * 2017-07-20 2017-11-03 北京泱深生物信息技术有限公司 A kind of diagnosis marker and its therapeutic targets of larynx squamous carcinoma

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2506066A1 (en) 2002-11-15 2004-06-03 Genomic Health, Inc. Gene expression profiling of egfr positive cancer
BRPI0706511A2 (en) 2006-01-11 2011-03-29 Genomic Health Inc gene expression markers for colorectal cancer prognosis
WO2007123772A2 (en) 2006-03-31 2007-11-01 Genomic Health, Inc. Genes involved in estrogen metabolism
US8765383B2 (en) 2009-04-07 2014-07-01 Genomic Health, Inc. Methods of predicting cancer risk using gene expression in premalignant tissue
WO2010127322A1 (en) 2009-05-01 2010-11-04 Genomic Health Inc. Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer and response to chemotherapy
EP2913405B1 (en) 2010-07-27 2016-11-09 Genomic Health, Inc. Method for using gene expression to determine prognosis of prostate cancer
WO2012154983A2 (en) 2011-05-10 2012-11-15 Biocare Medical, Llc Systems and methods for anti-pax8 antibodies
JP6351112B2 (en) 2012-01-31 2018-07-04 ジェノミック ヘルス， インコーポレイテッド Gene expression profile algorithms and tests to quantify the prognosis of prostate cancer
EP2900265B1 (en) 2012-09-27 2018-05-30 Biocare Medical, LLC Anti-uroplakin ii antibodies systems and methods
US10429390B2 (en) 2012-12-18 2019-10-01 Biocare Medical, Llc Antibody cocktail systems and methods for classification of histologic subtypes in lung cancer
JP6445467B2 (en) 2013-02-28 2019-01-09 バイオケア メディカル， エルエルシー Anti-P40 antibody system and method
WO2015051320A2 (en) 2013-10-03 2015-04-09 Biocare Medical, Llc Anti-sox10 antibody systems and methods
IT201700109459A1 (en) * 2017-09-29 2019-03-29 Univ Degli Studi Di Perugia METHOD TO PERFORM PROGNOSIS OF BREAST CANCER, KITS AND THE USE OF THESE
CN111159409B (en) * 2019-12-31 2023-06-02 腾讯科技（深圳）有限公司 Text classification method, device, equipment and medium based on artificial intelligence
CN112816431A (en) * 2020-09-22 2021-05-18 西华师范大学 Dual-wavelength capillary electrophoresis detection system for detecting tumor marker
CN117594133A (en) * 2024-01-19 2024-02-23 普瑞基准科技（北京）有限公司 Screening method of biomarker for distinguishing uterine lesion type and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001074405A1 (en) * 2000-03-31 2001-10-11 Gene Logic, Inc. Gene expression profiles in esophageal tissue
WO2001094629A2 (en) * 2000-06-05 2001-12-13 Avalon Pharmaceuticals Cancer gene determination and therapeutic screening using signature gene sets

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001074405A1 (en) * 2000-03-31 2001-10-11 Gene Logic, Inc. Gene expression profiles in esophageal tissue
WO2001094629A2 (en) * 2000-06-05 2001-12-13 Avalon Pharmaceuticals Cancer gene determination and therapeutic screening using signature gene sets

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
AMATSCHEK STEFAN ET AL: "Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific gene.", CANCER RESEARCH, vol. 64, no. 3, 1 February 2004 (2004-02-01), pages 844 - 856, XP001206325, ISSN: 0008-5472 *
CHANG K ET AL: "FREQUENT EXPRESSION OF THE TUMOR ANTIGEN CAK1 IN SQUAMOUS-CELL CARCINOMAS", INTERNATIONAL JOURNAL OF CANCER, NEW YORK, NY, US, vol. 51, no. 4, 19 June 1992 (1992-06-19), pages 548 - 554, XP002038952, ISSN: 0020-7136 *
HUDELIST GERNOT ET AL: "Use of high-throughput protein array for profiling of differentially expressed proteins in normal and malignant breast tissue.", BREAST CANCER RESEARCH AND TREATMENT. AUG 2004, vol. 86, no. 3, August 2004 (2004-08-01), pages 281 - 291, XP001206326, ISSN: 0167-6806 *
NEMOTO TETSUO ET AL: "Overexpression of protein tyrosine kinases in human esophageal cancer", PATHOBIOLOGY, vol. 65, no. 4, July 1997 (1997-07-01), pages 195 - 203, XP009048170, ISSN: 1015-2008 *
SÁNCHEZ-CARBAYO MARTA: "Use of high-throughput DNA microarrays to identify biomarkers for bladder cancer.", CLINICAL CHEMISTRY. JAN 2003, vol. 49, no. 1, January 2003 (2003-01-01), pages 23 - 31, XP001206327, ISSN: 0009-9147 *
VAN HEEK N TJARDA ET AL: "Gene expression profiling identifies markers of ampullary adenocarcinoma.", CANCER BIOLOGY & THERAPY. JUL 2004, vol. 3, no. 7, July 2004 (2004-07-01), pages 651 - 656, XP009048026, ISSN: 1538-4047 *
WU L ET AL: "MOLECULAR CLONING OF THE HUMAN CAK1 GENE ENCODING A CYCLIN-DEPENDENT KINASE-ACTIVATING KINASE", ONCOGENE, BASINGSTOKE, HANTS, GB, vol. 9, no. 7, 1 July 1994 (1994-07-01), pages 2089 - 2096, XP000673011, ISSN: 0950-9232 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107312854A (en) * 2017-07-20 2017-11-03 北京泱深生物信息技术有限公司 A kind of diagnosis marker and its therapeutic targets of larynx squamous carcinoma

Also Published As

Publication number Publication date
WO2005076005A2 (en) 2005-08-18

Similar Documents

Publication Publication Date Title
WO2005076005A3 (en) A method for classifying a tumor cell sample based upon differential expression of at least two genes
WO2007065025A3 (en) Method of dna analysis using micro/nanochannel
WO2008014280A3 (en) Flourescent dyes for use in glucose sensing
WO2007061876A8 (en) Methods and compositions involving intrinsic genes
WO2007047680A3 (en) Increasing the activity of radical s-adenosyl methionine (sam) enzymes
WO2006089091A3 (en) Methods for detecting minimum residual disease
WO2004072238A3 (en) Terminal-phosphate-labeled nucleotides with new linkers
WO2005090603A3 (en) Method for diagnosing non-small cell lung cancer
WO2004058990A3 (en) Genetic polymorphisms associated with stenosis, methods of detection and uses thereof
WO2003039443A3 (en) Novel genetic markers for leukemias
WO2004074425A3 (en) Method and device for the formation of biological cell material
WO2008100892A3 (en) Fungal endophytes of elymus canadensis
WO2006071466A8 (en) Methods and nucleic acids for the analysis of gene expression associated with the prognosis of prostate cell proliferative disorders
WO2010039627A3 (en) Biodetection articles
WO2005087951A3 (en) Reagents, methods and kits for use in deactivating nucleic acids
WO2006091924A3 (en) Producing carotenoids
WO2002046465A3 (en) Method for identification of genes involved in specific diseases
WO2006017751A3 (en) Methods for the detection of molecular interactions within cells
WO2004061458A3 (en) Hsc70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease
WO2007002762A3 (en) Components of cell culture media produced from plant cells
WO2006004728A3 (en) Cell culture medium comprising transition metals or trace elements
WO2002002740A3 (en) Methods and compositions for determining gene function
WO2005054517A3 (en) Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders
WO2007031949A3 (en) Liquid media for chlamydospore production of the fungus pochonia chlamydosporia
WO2005103229A3 (en) Transgenomic mitochondria, transmitochondrial cells and organisms, and methods of making and using

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase